Hydrus Microstent implantation with OMNI Surgical System Ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy
- PMID: 36544749
- PMCID: PMC9762144
- DOI: 10.1016/j.ajoc.2022.101749
Hydrus Microstent implantation with OMNI Surgical System Ab interno canaloplasty for the management of open-angle glaucoma in phakic patients refractory to medical therapy
Abstract
Purpose: To report a series of 8 phakic eyes of 8 patients with open angle glaucoma with uncontrolled intraocular pressure on maximum tolerable medical therapy receiving Hydrus Microstent implants combined with concomitant OMNI Surgical System ab interno canaloplasty.
Observations: 8 phakic eyes underwent Hydrus Microstent implantation with OMNI Surgical System ab interno canaloplasty. 2 patients underwent concurrent Kahook Dual Blade goniotomy and 1 patient underwent a concurrent micropulse transscleral cyclophotocoagulation. 6 out of 8 eyes achieved successful intraocular pressure reduction. Only 1 achieved success without the need for additional medical therapy. 1 required Neodymium-doped yttrium aluminum garnet laser to clear iris obstruction of the Hydrus inlet and 1 required selective laser trabeculoplasty for additional intraocular pressure lowering. 2 out of 8 eyes required subsequent incisional glaucoma surgery for unacceptable intraocular pressure levels despite maximum tolerable medical therapy.
Conclusions and importance: The Hydrus Microstent combined with OMNI Surgical System ab interno canaloplasty can safely and successfully reduce intraocular pressure in phakic patients with open-angle glaucoma with uncontrolled intraocular pressure on maximum tolerable medical therapy with a low complication rate and rapid visual recovery.
Keywords: Glaucoma; Hydrus microstent; MIGS; Minimally invasive glaucoma surgery; OMNI Surgical system; Phakic.
© 2022 The Authors. Published by Elsevier Inc.
Conflict of interest statement
The following authors have no financial disclosures: J.C.; W.K.; C.S.
References
-
- Gulati V., Fan S., Hays C.L., Samuelson T.W., Ahmed I.I.K., Toris C.B. A novel 8-mm Schlemm's canal scaffold reduces outflow resistance in a human anterior segment perfusion model. Investig Ophthalmol Vis Sci. 2013;54(3):1698–1704. - PubMed
-
- Shareef S., Fea A., Ahmed I.I.K. The hydrus micro-stent. Surgical Innovations in Glaucoma. 2013:171–174.
-
- Samuelson T.W., Chang D.F., Marquis R., et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126(1):29–37. - PubMed
-
- Ahmed I.I.K., Fea A., Au L., et al. A prospective randomized trial comparing hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study. Ophthalmology. 2020;127(1):52–61. - PubMed
-
- Vold S.D., Williamson B.K., Hirsch L., et al. Canaloplasty and trabeculotomy with the OMNI system in pseudophakic patients with open-angle glaucoma: the ROMEO study. Ophthalmology Glaucoma. 2021;4(2):173–181. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical